Accelerating protein engineering.
Company is closed
Event Year: 2020
Company is closed
Event Year: 2020
Trident Bioscience was focused on revolutionizing protein engineering through the development of advanced tools. Their core technology leveraged predictive models of protein structure and function to generate promising protein sequences. Subsequently, they employed a sophisticated sequence optimization algorithm to design gene libraries, enabling rapid and cost-effective testing of these candidate proteins. By integrating these technologies, Trident aimed to streamline the protein optimization process, significantly reducing the time required to bring synthetic proteins to market. This integrated approach sought to accelerate the design-build-test cycle, offering a faster path to commercialization for synthetic proteins.
Trident Bioscience was focused on revolutionizing protein engineering through the development of advanced tools. Their core technology leveraged predictive models of protein structure and function to generate promising protein sequences. Subsequently, they employed a sophisticated sequence optimization algorithm to design gene libraries, enabling rapid and cost-effective testing of these candidate proteins. By integrating these technologies, Trident aimed to streamline the protein optimization process, significantly reducing the time required to bring synthetic proteins to market. This integrated approach sought to accelerate the design-build-test cycle, offering a faster path to commercialization for synthetic proteins.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2020
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2020
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 1
Hiring: No
Team size: 1
Hiring: No